Acadia Pharmaceuticals (ACAD) Interest Coverage Ratio (2018 - 2019)
Acadia Pharmaceuticals (ACAD) recorded quarterly Interest Coverage Ratio of 4757.58 in Q2 2019, down 1143.22% quarter-over-quarter from 382.68 in Q1 2019, and down 1733.87% on a YoY basis from 291.19 in Q2 2018.
Acadia Pharmaceuticals (ACAD) Interest Coverage Ratio (2018 - 2019) Analysis & Trends
Acadia Pharmaceuticals' Interest Coverage Ratio history runs 2 years deep, the most recent figure standing at 4757.58 for Q2 2019.
- In Q2 2019, Interest Coverage Ratio fell 1733.87% year-over-year to 4757.58; the TTM figure through Mar 2020 stood at 20702.17 (down 50866.53% YoY), while the FY2018 annual figure was 27.84, changed N/A from the prior year.
- Interest Coverage Ratio was 4757.58 for Q2 2019 at Acadia Pharmaceuticals, down from 382.68 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 35.62 in Q3 2018 to a low of 4757.58 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Acadia Pharmaceuticals | 3.68 Bn | 2.83 Bn | 243.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -4,757.58 |
| Mar 31, 2019 | -382.68 |
| Dec 31, 2018 | -1,015.30 |
| Sep 30, 2018 | -35.62 |
| Jun 30, 2018 | -259.43 |